The appropriate use of the clinical microbiology laboratory for diagnosing lower respiratory tract infections is controversial. As in clinical care, it is crucial to categorize the presenting illness properly as acute bronchitis, an acute exacerbation of chronic bronchitis, community-acquired pneumonia, or nosocomial pneumonia if diagnostic efforts to establish a microbial etiology are to be productive for the individual patient and affordable to society. The greatest potential benefit of microbiological investigations lies in the etiologic diagnosis of pneumonia. For community-acquired pneumonia, evaluation of a gram-stained smear of sputum in terms of both quality and microorganisms present can help guide initial therapy as well as aid interpretation of subsequent culture results. As discussed in this review, the role of the clinical microbiology laboratory in the etiologic diagnosis of nosocomial and complicated pneumonias is more extensive and, in addition to evaluation of respiratory secretions, may include cultures of blood, pleural fluid, and specimens obtained by bronchoscopy. However, a prerequisite for the use of all currently available tests is their deployment for patients with clinical and radiographic evidence of pneumonia.
Lower respiratory tract infections, including acute and (COPD) is an added predisposing factor in the development chronic bronchitis, community-acquired pneumonia, nosocoof acute bronchitis. The distinction between de novo acute mially acquired pneumonia, and pneumonia in immunobronchitis and acute exacerbations of chronic bronchitis in compromised hosts, are among the most common major infecsmokers may be of little relevance in terms of laboratory practious illnesses [1] . Changes in the characteristics of the tice. Anatomically, both the trachea and bronchial tree are usupopulation, such as the number of individuals over age 65, the ally involved. Infection usually begins as part of an acute viral number of individuals in nursing homes, and the number of infection, but sputum may become purulent, and cultures will patients with immunocompromising conditions, have increased commonly yield bacterial agents including Streptococcus pneuthe number of individuals at risk, the number of infections that moniae, Haemophilus influenzae, Moraxella catarrhalis, occur, and the variety of pathogens known to cause infection.
and/or other organisms that commonly colonize the upper resThe role of the microbiology laboratory in the diagnosis of piratory tract, especially in patients with COPD. Other unique milder cases of acute bronchitis and community-acquired pneurespiratory pathogens, including Chlamydia pneumoniae, Mymonia has been challenged. Even for seriously ill patients, coplasma pneumoniae, and Bordetella pertussis, have also been controversy exists over the diagnostic value of many specimens cultured in specimens from patients with acute and chronic obtained routinely, as well as those that are obtained via more cough. The role any recovered bacterial pathogen plays in the invasive procedures such as bronchoscopy. This review will pathogenesis of illness in an individual patient is always diffiaddress the laboratory tests available and their limitations in cult to determine. the diagnosis of lower respiratory tract infections.
The value of microbiological studies to determine the infectious etiology of acute bronchitis in otherwise healthy individuals has not been established. No comparative studies of differAcute Bronchitis ent laboratory methods for such patients have been published. Acute bronchitis results from inflammation of the bronchial Anecdotally, many of these infections are viral in nature. Cultree, usually after an upper respiratory tract infection. For tures of sputum specimens will ordinarily yield bacteria, smokers, ongoing but indolent inflammation with chronic spuwhether or not infection is present, and such growth is just as tum production due to chronic obstructive pulmonary disease likely to represent upper airway colonization as lower respiratory tract infection [2] . Similarly, microbiological methods are of limited value in identifying pathogenic organisms and planning treatment for exists in the approach to the management of these infections [7, 8] .
In summary, there is no straightforward evidence that performing gram stains or cultures of sputum samples helps in A list of common organisms associated with communityacquired pneumonia is provided in table 1. Geographic and determining the etiology of acute bronchitis. Given the likelihood that these infections are most often caused by viruses or patient population characteristics are important when considering possible etiologies in individual patients [12] . For example, atypical organisms, it would be more plausible to perform special studies to identify these agents. However, too little research Coxiella burnetti is a common cause of pneumonia in Nova Scotia, Coccidioides imitis is a common cause in Arizona, and has been done in this area to support the routine use of these studies as diagnostically helpful or cost-effective.
Pneumocystis carinii is a common cause in patients with HIV infection. However, even when a variety of test methods are used and specimen types are evaluated, the etiologic agent is not identified in a large proportion of cases.
Community-Acquired Pneumonia
Controversy over the list of pathogens and the frequency with which they cause infection is widely acknowledged [10, Community-acquired pneumonia is a disease caused by a wide variety of microorganisms and has a spectrum of severity 12, 15, 16, 18 -20] . Multiple factors contribute to the difficulty in arriving at a diagnosis. Many patients do not have a producthat ranges from mild illness treated in the outpatient setting to severe disease associated with a high mortality rate [9] . Risk tive cough or are too weak to provide a deeply produced specimen. Even deep samples are inherently contaminated with upfactors associated with severe disease have been described in detail [10, 11] .
per respiratory tract secretions that contain an array of organisms that are also potential etiologic agents of pneumonia. Effective use of the clinical microbiology laboratory in determining the etiology of pneumonia depends on a reasonably A significant percentage of patients have received antimicrobial agents before presentation, thus reducing the ability to recover established clinical diagnosis that is based on a patient's history, physical findings, and radiographic findings. Symptoms the actual pathogen. Finally, there are a number of etiologic agents commonly associated with pneumonia such as M. pneuof acute pneumonia are generally straightforward and most commonly include fever, chills, dyspnea, pleuritic chest pain, moniae, C. pneumoniae, C. burnetti, and respiratory viruses that are not readily cultured by usual laboratory means. and cough [12, 13] . Although it has been suggested that disease patterns, such as rapidity of onset, sputum production, and
The role of the microbiology laboratory is the detection of the etiologic agent causing the infection. Approaches that can the presence of pleuritic chest pain, allow distinction between categories of etiologic agent [1, 14] , these patterns are not be used include analysis of sputum by culture and gram stain, culture of normally sterile specimens such as blood and pleural helpful in individual cases [12, 15] .
Hematologic and biochemical findings may be of some help fluid, and serological tests. Sputum is the most common specimen obtained, but it is also the one that is most problematic. in establishing the severity of the disease and the need for hospitalization [16] . However, such findings will not be of Attempts to improve the quality and reliability of sputum specimens have included improved specimen collection methods: benefit in determining an etiologic agent, with the possible exception of the hyponatremia and elevated creatine phosphono ingestion of food for 1 -2 hours; rinsing the mouth with water, saline, or other mouthwashes; bedside inoculation of kinase levels that occur during Legionella pneumophila infections [17] . culture media; expedited transport of specimens to the labora-/ 9c48$$mr30 02-06-98 00:11:17 cida UC: CID should include media to allow recovery of the common bacterial pathogens. Typically, blood agar, chocolate agar, and MacConkey agar plates are inoculated. In particular, the use of blood agar aids in colony recognition of gram-positive organtory; immediate inoculation of specimens upon arrival in the isms and in the recognition of the hemolytic patterns of streptolaboratory; use of selective media for pneumococci, such as cocci. The use of chocolate agar increases recovery of fastidigentamicin-containing blood agar plates; anaerobic incubation ous organisms like H. influenzae. MacConkey agar can be used of agar media; and use of techniques to identify bacterial antito selectively recover gram-negative bacteria and establish gens directly in sputum. Since there is no definitive test to whether the organisms are lactose fermenters. Horse blood prove the utility of any method involving sputum, claims that agar may be used to simplify the recognition of hemolysis by these procedures are beneficial cannot be established with cerHaemophilus species. tainty. The results of a study to determine the utility of sputum Culture samples that may be more useful for identifying the induction to obtain samples with less upper respiratory tract specific etiologic agent causing pneumonia include blood and contamination have recently been published; no benefit was pleural fluid and, occasionally, other samples such as CSF. It demonstrated with this method [21] .
has been suggested recently that blood cultures should not be One method that has been established as being beneficial is performed routinely in the setting of mild, community-acquired the use of a microscopic sputum screen by gram stain for evidence pneumonia because of a sensitivity rate of only 10% -30% of upper respiratory tract contamination and, when such contami-
[28]. The counterargument is that a benefit still exists when nation is not found, for a predominant bacterial morphological the blood culture is positive, since this result definitively identitype. When a specimen is inadequate according to the criteria fies the pathogen. The pathogen recovered may be unexpected discussed below, it can be rejected, and a new one can be reand may have an unusual antimicrobial resistance pattern [29, quested. Such repeated samples ideally should be obtained after 30] . There is less debate about the value of pleural fluid culfurther patient instruction and with observation of the patient tures. When a clinically important effusion is present, the perduring the collection process [22] . When a specimen is viewed formance of aspiration is critical for diagnosis and, potentially, under low power with the 101 objective, the number of epithelial for treatment. Other distant sites that are normally sterile, such and/or polymorphonuclear leukocytes (PMNs) present helps deas CSF, should also be cultured when clinical symptoms sugtermine the degree of upper respiratory tract contamination. The gest infection at those sites. presence of many epithelial cells suggests too much contamina-
The diagnostic approach for organisms such as Mycobactetion, the absence of these cells and the presence of large numbers rium tuberculosis, Legionella species, and P. carinii is different of PMNs suggest less contamination, and the presence of mucus from that for common bacterial pathogens because the former stranding suggests that inflammation (hence, infection) is present.
are never considered normal colonizing flora, and screening Multiple specific criteria incorporating epithelial cells, PMNs, procedures are not considered as important in such cases. and mucus stranding in variable combinations and with variable
Whereas poor-quality specimens may result in decreased yield, numbers required for each cell type have been published (table the growth of one of these organisms -even from a poor-2) [23] . However, none of the published criteria have been clearly quality sample -suggests disease. In one study, screening was established as superior.
shown to decrease the time spent processing low-quality speciVisualization of a predominant bacterial morphology may mens for M. tuberculosis [31] , but a number of other studies be useful in predicting the etiologic agent, especially if it is have shown acceptable recovery of these organisms, even from S. pneumoniae [24, 25]. As stated above, however, a screening samples that would be considered inadequate on the basis of procedure that identifies a sample as adequate does not establish microscopic screening [32] . the diagnosis of pneumonia. The screening procedure should
The diagnosis of infection due to these unique organisms requires an accurate clinical history that suggests their presbe performed as soon as the sample arrives in the laboratory.
/ 9c48$$mr30
02-06-98 00:11:17 cida UC: CID ence, the use of appropriate media for organisms easily grown in vitro, and the use of serological tests [30, 33] 
Nosocomial Pneumonia
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The diagnosis of lower respiratory tract infection in hospital-NOTE. Data are from [13, 34] .
ized patients is often more difficult than the diagnosis of com-/ 9c48$$mr30 02-06-98 00:11:17 cida UC: CID problems for hospitalized patients as for patients in the commuThe use of additional selective and differential media may be considered more important for hospitalized patients. In cases nity. Since the mortality rates are higher for patients with hospital-acquired infection, the incentive to arrive at a specific diagof severe, life-threatening disease, evaluation for the presence of Legionella species should be done routinely. The approach nosis is greater. Cultures of sterile sites like blood and pleural fluid are performed routinely [13, 35] . The use of more-invasive should include culture of directly obtained respiratory specimens and testing for Legionella urinary antigen; direct fluoresprocedures to obtain less-contaminated specimens directly from the lower respiratory tract is also encouraged, especially for cent antibody testing of sputum is less sensitive and technically more demanding [1, 16, 46] . Procedures that may be done patients who are already intubated.
The suctioning of secretions from an endotrachial tube is selectively include serologies for Mycoplasma and Chlamydia; culture and serology for influenza virus; culture, serology, and the least invasive of these approaches. The utility of these specimens is controversial and perhaps limited [36] . Some indirect antigen detection for respiratory syncytial virus; acidfast smears and culture for mycobacteria; and direct fluorescent vestigators have proposed screening criteria for endotrachial secretions, similar to those used for expectorated sputum. Careantibody testing or specific stains for P. carinii. It is important to note that while direct antigen or antibody testing can identify ful review of the experience with these specimens suggests that they are no better than expectorated sputum for the diagnosis an etiologic agent immediately, serological diagnoses typically are made late in the course of illness, after most therapeutic of pneumonia and have all the same limitations with respect to possible upper respiratory tract contamination, even with decisions have already been made. Finally, while not yet routine, amplification procedures for screening procedures [36] .
Performing bronchoscopy to obtain specimens is more likely the diagnosis of respiratory tract pathogens are under active development. M. pneumoniae, C. pneumoniae, and L. pneuto be of benefit. Samples that can be obtained include bronchial washings, bronchial brushings, bronchoalveolar lavage (BAL) mophila have all been identified from throat swabs as well as in BAL fluid with use of DNA amplification by PCR [47] . The fluid, and transbronchial biopsy specimens [37] . Bronchoscopy has been advocated as a method of establishing a diagnosis sensitivities and specificities of these assays can not be stated because the true incidence of infection with these organisms of nosocomial pneumonia as well as a way to determine the microbiological diagnosis [38] . Published sensitivity and specihas not been reliably established. ficity rates for the use of protected brushes and BAL have approached 80% -90% [37 -39] ; quantitative methods have been described as the most discriminating. However, rates of Pneumonia in Immunocompromised Hosts false positivity, even when quantitative techniques are used, have approached 30% -40% in some studies [40, 41] , and atPatients with significant immunocompromising conditions represent a separate category for clinical evaluation, since the tempts to reset thresholds for quantitation are ongoing [41 -44] . Thresholds have been set as low as 10 3 cfu/mL and as list of pathogens includes a number of opportunistic organisms that would not infect immunologically intact hosts. Specific high as 10 6 cfu/mL. The problem that is always identified is that a higher threshold is associated with a higher specificity diagnosis of the microbial etiology of disease is critical for these patients, given a wider variety of therapeutic options, but lower sensitivity and vice versa, with no clear quantitative value that provides an adequate level for both. some of which would not routinely be exercised because of cost, toxicity, or both. Clinical information, including the patMost telling is a study in which all bronchoscopic procedures were compared with immediate postmortem lung cultures for tern of disease on chest radiographs, may be helpful in targeting the diagnostic approach [48], but a broad list of pathogens patients with fatal ventilator-associated pneumonia [45] . The sensitivities of bronchoscopic procedures ranged from 25% to 50%, should generally be considered. Culture of expectorated or induced sputum samples may allow identification of the pathoand the specificities ranged from 45% to 79%. Therefore, the role of bronchoscopic specimens for the diagnosis of pneumonia gen; if not, the performance of bronchoscopy to obtain BAL fluid and transbronchial biopsy specimens may be essential. due to common bacterial pathogens is still unclear. Particular situations in which bronchoscopic collection is clearly useful There is less controversy regarding the diagnostic utility of fiberoptic bronchoscopy in this setting. Baselski and Wunderinclude suspected cases of tuberculosis in which sputum smears are negative and chronic, unexplained pulmonary conditions in ink [37] described in detail the pitfalls of improper specimen collection and the importance of appropriate technique when otherwise immunocompetent hosts [13] . Unexpected bacterial, viral, or fungal pathogens, as well as neoplasms and other nonhandling bronchoscopic specimens. Two diagnostic approaches have been described: the serial dilution method, in which two infectious conditions, may be detected in such situations.
The final approach to collecting diagnostic material from 100-fold dilutions are made, followed by plating of a measured 0.1-mL amount of material on agar media, with direct colony hospitalized patients is direct, transthoracic, fine-needle aspiration. This technique is generally reserved for solitary masses, counts reported in cfu/mL; and the ''calibrated loop'' method, in which a method similar to urine plating is used. Established fluid collections, and nodules and should not be used for diagnosing common pneumonias [13] .
thresholds for contamination vs. infection are ú 10 3 cfu/mL / 9c48$$mr30 02-06-98 00:11:17 cida UC: CID fungi; mycobacteria; and respiratory and herpes viruses as well
